IGF2BP1 and cancer: This direct m6A-dependent stabilization of EZH2 mRNA by IGF2BP1 further underlines its oncogenic role in cancer, which so far has mainly been attributed to its inhibitory action on miRNA/RISC-directed downregulation of antiproliferative target mRNAs [14,17,30,61,62].